Results 51 to 60 of about 2,319 (150)

Effects of Omidenepag Isopropyl Versus Latanoprost Eye Drops on Intraocular Pressure, Pupil Diameter, and Anterior Chamber Parameters in Normal Feline Eyes: A Pilot Study

open access: yesVeterinary Ophthalmology, Volume 29, Issue 2, March 2026.
ABSTRACT Objectives This study aimed to compare the effect of the newly developed selective prostaglandin E2 receptor agonist, omidenepag isopropyl (OMDI), and latanoprost on intraocular pressure (IOP), pupil diameter (PD), and anterior chamber parameters in normal feline eyes.
Sang‐Eun Park   +5 more
wiley   +1 more source

Adjunctive therapy with brinzolamide in patients on travoprost treatment

open access: yes, 2011
Introduction. This study was aimed at evaluating the safety and efficacy of brinzolamide 1% suspension (Azopt? 1%) and travoprost 0.004% (Travatan?) combined therapy in patients with open-angle glaucoma or ocular hypertension who are in need of ...
Vladimir Canadanovic   +4 more
core   +1 more source

Brinzolamide-induced retinopathy in neonatal rats: an alternative animal model of retinal neovascularization [PDF]

open access: yes, 2014
Background and Purpose: Neovascular retinal pathology is steel uncertain. Thus, there is great need to investigate new modeling, diagnostic and treatment technologies.
BILETSKA, P.V.   +5 more
core   +1 more source

Ultrasonographic Appearance of a Posterior Lenticonus in a Cat

open access: yesVeterinary Ophthalmology, Volume 29, Issue 1, January 2026.
ABSTRACT The objective of this study is to present high‐quality and up‐to‐date ocular ultrasonographic images and videos of a posterior lenticonus with concomitant mature cataract in a cat. Additionally, the clinical findings, surgical treatment, and outcome are reported for completeness and to confirm the diagnosis.
Antonella Rampazzo   +2 more
wiley   +1 more source

Corneal Anterior and Posterior Changes in a Patient With Keratitis Associated With Mycobacterium chelonae: A Case Report

open access: yesCase Reports in Ophthalmological Medicine, Volume 2026, Issue 1, 2026.
Purpose This report describes a patient with anterior and posterior corneal topographic changes who developed refractory keratitis due to Mycobacterium chelonae, associated with soft contact lens use. Case A 42‐year‐old man presented with blurred vision and pain in his right eye. He used disposable soft contact lenses for 2 weeks with appropriate care.
Ryo Kato   +8 more
wiley   +1 more source

Carbonic Anhydrase Inhibitors in the Treatment of Glaucoma. Review. Part I

open access: yesOftalʹmologiâ, 2020
Glaucoma is the main cause of irreversible blindness in the world. Carbonic anhydrase inhibitors (CAIS) used both systemically and topically, reduce intraocular pressure effectively.
N. I. Kurysheva
doaj   +1 more source

Comparisons of Intraocular-Pressure- Lowering Efficacy and Side Effects of 2% Dorzolamide and 1% Brinzolamide

open access: yes, 2001
Forty-one healthy volunteers were recruited for a study to compare the intraocular pressure (IOP)-lowering efficacy and side effects of 2% dorzolamide and 1% brinzolamide.
성공제
core   +1 more source

Euler and Gourava Sombor Coindices Bounds and Python‐Based QSPR Modeling for Butane Derivatives and Ocular Pharmaceuticals

open access: yesJournal of Chemistry, Volume 2026, Issue 1, 2026.
Topological indices are crucial in modeling of molecular structures of graphs and are also useful in correlation with physicochemical properties. In this paper, we propose the Euler Sombor coindex and Gourava Sombor coindex, and we derive bounds by using some graph invariants of a graph such as the degree of a vertex, the order, and the size of a graph.
Suha Wazzan   +2 more
wiley   +1 more source

Clinical Experience with Timolol and Brinzolamide Fixed-combination: A Case Series

open access: yesOftalʹmologiâ
One of the approaches to improve the adherence of patients with primary open-angle glaucoma (POAG) to IOP-lowering eye drops therapy is the use of fixed-combinations (FC), since this makes it possible to reduce treatment cost during combined therapy ...
S. V. Yanchenko   +3 more
doaj   +1 more source

Novel Sulfonylhydrazones With Sulfonate Ester Framework: Promising Dual Inhibitors of AChE and hCAs

open access: yesBiotechnology and Applied Biochemistry, Volume 72, Issue 6, Page 1752-1762, December 2025.
ABSTRACT Alzheimer's disease (AD) is a progressive neurodegenerative disorder that affects millions of individuals worldwide. Treatment strategies for AD vary depending on cognitive and behavioral symptoms, with cholinergic replacement therapy using acetylcholinesterase (AChE) inhibitors being one of the primary approaches.
Cansu Öztürk   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy